This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

News Articlesrss feed

Professor Cecilia Lindgren appointed Director of the Big Data Institute

Professor Cecilia Lindgren has been appointed as the new Director of the University of Oxford’s Big Data Institute. The availability of biomedical information, also known as ‘big data’, is increasing rapidly. The analysis of this data provides an opportunity for transforming the scale and efficiency of large-scale clinical research and care. The Big Data Institute (BDI) […]

CONFIDENTIAL COUNSELLING FOR COVID-19 PATIENTS’ LOVED ONES

Oxford University Hospitals is now providing ‘In the Moment’ support for the relatives, ‘support bubble’ members or friends of our COVID-19 inpatients. Qualified Trust counsellors can offer a 45 minute telephone counselling appointment, and direct people in need of further support to community services and charities, such as CRUSE, Talking Space or Oxford Health NHS […]

World’s largest clinical trial for COVID-19 treatments expands internationally

he Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International. Peter Horby, Professor of Emerging Infectious Diseases and Global Health in the Nuffield Department of Medicine, University […]

Entrepreneurs set to benefit from new centre at Oxford Brookes University

The Oxfordshire Local Enterprise Partnership (OxLEP) has announced a new part-Government funded project – delivered in collaboration with Oxford Brookes University – set to promote entrepreneurship and support start-up businesses in the county. The new Oxford Brookes Enterprise Centre will give companies access to lab spaces, experts and professional networks. It’s hoped that the new […]

Oxford University extends COVID-19 vaccine study to children

The University of Oxford, together with three partner sites in London, Southampton and Bristol, is to launch the first study to assess the safety and immune responses in children and young adults of the ChAdOx1 nCoV-19 coronavirus vaccine. Our vaccine work is progressing quickly. To ensure you have the latest information or to find out […]

LATERAL FLOW DEVICES FOUND TO BE USEFUL IN SCREENING OUH STAFF FOR CORONAVIRUS

Infection prevention and control clinicians and researchers at Oxford University Hospitals (OUH) have been outlining the OUH’s experience of deploying self-administered home-based lateral flow testing of its staff. In a letter published in the Journal of Infection, they said that 46,503 home-based SARS-CoV-2 lateral flow tests had been performed by asymptomatic OUH hospital staff. Of these, […]

100 Women of Oxford Medical Sciences

100 years since women were admitted as full members of the University of Oxford, women now hold vital posts at all levels of this institution. Across 16 departments and numerous affiliated units, the women of Medical Sciences come from all walks of life, from all backgrounds, from all over the world. In the Medical Sciences […]

Tocilizumab reduces deaths in patients hospitalised with COVID-19

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) has demonstrated that an anti-inflammatory treatment, tocilizumab, reduces the risk of death when given to hospitalised patients with severe COVID-19. The study also showed that tocilizumab shortens the time until patients are successfully discharged from hospital and reduces the need for a mechanical ventilator. The RECOVERY trial has been testing […]

COMMON ASTHMA TREATMENT REDUCES NEED FOR HOSPITALISATION IN COVID-19 PATIENTS, STUDY SUGGESTS

Early treatment with a medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalisation in people with COVID-19, researchers at the University of Oxford have found. The STOIC study found that inhaled budesonide given to patients with COVID-19 within seven days of the onset of symptoms also reduced recovery time. […]

ChAdOx1 nCov-19 provides minimal protection against mild-moderate COVID-19 infection from B.1.351 coronavirus variant in young South African adults

In an analysis, submitted as a pre-print prior to peer-review publication, a two-dose regimen of the ChAdOx1 nCoV-19 vaccine provides minimal protection against mild-moderate COVID-19 infection from the B.1.351 coronavirus variant first identified in South Africa. Our vaccine work is progressing quickly. To ensure you have the latest information or to find out more about […]